ATP1A3 and optic atrophy: For example, our previous study reported an ANSD patient carrying an ATP1A3 variant without pathognomonic features and presenting a cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS) phenotype41.